Search

Search Constraints

You searched for: Author/Creator Verlingue, Loic

Search Results

2. Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials. (July 2014)

3. Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas. (February 2018)

4. Corrigendum to "Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial" [Eur J Cancer 87 (2017) 122–130]. (April 2018)

5. Epigenetic gene alterations in metastatic solid tumours: results from the prospective precision medicine MOSCATO and MATCH-R trials. (September 2022)

6. Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door. (March 2018)

7. Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine. (October 2017)

9. Natural Language Processing for Patient Selection in Phase I or II Oncology Clinical Trials. (2021)

10. Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial. (December 2017)